Biographies of Committee Members
MARYANN P. FELDMAN (CO-CHAIR)
Dr. Maryann P. Feldman is Heninger distinguished professor in the Department of Public Policy and professor of finance at the Kenan-Flagler Business School at the University of North Carolina. Her research and teaching interests are focused on innovation, the commercialization of academic research, and the factors that promote technological change and economic growth. From 2014 to 2017, Dr. Feldman held a joint appointment at the National Science Foundation as the Science of Science and Innovation Policy program director. Dr. Feldman’s early work revealed that universities were necessary, but not sufficient, for technology-based economic development. These findings launched a new area of investigation into university technology transfer. She has written extensively on processes and mechanisms to commercialize academic research, areas germane to Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs. Dr. Feldman is currently co-chair of the National Academies of Sciences, Engineering, and Medicine Committee on the Review of the SBIR/STTR Programs at the National Science Foundation. Since 2016, Dr. Feldman has been a member of the National Academies Innovation Policy Forum (following a period as an ex officio member); she co-chaired the Committee on the Review of the SBIR/STTR Programs at the Department of Energy (2018–2020); and she served on the Workshop Steering Committee on Prioritizing and Implementing Improvements to Innovation Indicators (2015–2016). Dr. Feldman earned a Ph.D. in economics and management from Carnegie Mellon University.
SCOTT STERN (CO-CHAIR)
Dr. Scott Stern is David Sarnoff professor of management at the Massachusetts Institute of Technology Sloan School of Management. He explores how innovation and entrepreneurship differ from more traditional economic activities, and the consequences of these differences for strategy and policy. Dr. Stern’s research in the economics of innovation and entrepreneurship is focused
on entrepreneurial strategy, innovation-driven entrepreneurial ecosystems, and innovation policy and management. His recent studies include the impact of clusters on entrepreneurship, the role of institutions in shaping the accumulation of scientific and technical knowledge, and the drivers and consequences of entrepreneurial strategy—areas relevant to the committee’s task. Dr. Stern is currently co-chair of the National Academies of Sciences, Engineering, and Medicine Committee on the Review of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Programs at the National Science Foundation. His National Academies activity also includes serving on the Committee on the Evaluation of the Advanced Research Projects Agency-Energy (ARPA-E) Mission and Goals (2015–2017), chairing the workshop steering committee on Prioritizing and Implementing Improvements to Innovation Indicators (2015–2016), co-chairing the Committee on the Review of the SBIR/STTR Programs at the Department of Energy (2018–2020), serving on the Committee on the Impact of Copyright Policy on Innovation in the Digital Era (2010–2013), and serving on the Committee on the Future of Supercomputing (2003–2005). He co-founded and served as director of the National Bureau of Economic Research’s Innovation Policy Working Group from 1998 to 2021. Dr. Stern earned a Ph.D. in economics from Stanford University.
Dr. Gavi Begtrup is chief executive officer (CEO) at Eccrine Systems, Inc., a company founded in 2013 to commercialize technology and intellectual property covering diagnostic applications in sweat sensor technology. Prior to joining Eccrine in 2014, he founded and was principal at Polymath Strategies, LLC, where he specialized in technology commercialization and business development for small businesses and supported the Department of Energy in awarding grants and Small Business Innovation Research awards. Prior to founding Polymath, Dr. Begtrup was CEO of WaveTech, LLC, a technology startup that developed and produced light filters to increase productivity and yield in the algae and agriculture industries. From 2009 to 2012, he was policy advisor for Congresswoman Gabrielle Giffords and was the 2009–2010 American Association for the Advancement of Science/Materials Research Society/Optical Society of America congressional science fellow. He also was part of the 2008 Christine Mirzayan Science and Technology Fellowship class at the National Academies. Dr. Begtrup received a Ph.D. and M.A. in physics from the University of California, Berkeley and a B.S. in physics, mathematics, and computer science from Western Kentucky University.
EMILY COX PAHNKE
Dr. Emily Cox Pahnke is associate professor of management and organization at the University of Washington’s Foster School of Business. Her research focuses on understanding the resources that make ventures successful;
specifically, the effects of entrepreneurs’ identification and acquisition of resources on venture funding, innovation, and initial public offerings. Dr. Cox Pahnke’s research contributes by highlighting the boundary conditions under which resources that are typically considered beneficial to ventures—such as venture capital, well-connected partners, or star employees—can be unhelpful or even harmful. Dr. Cox Pahnke’s research has been funded by the receipt of a Schulze Entrepreneurship Professorship and by the Kauffman Foundation and the National Science Foundation. She received the Emerging Scholar Award from the Technology and Innovation Management Division of the Academy of Management. Dr. Cox Pahnke holds a Ph.D. in management science and engineering and an M.A. in sociology from Stanford University, and an M.B.A. in finance and a B.S. botany from Brigham Young University.
JOSHUA S. GRAFF ZIVIN
Dr. Joshua Graff Zivin holds the Pacific Economic Cooperation chair in international economic relations at the University of California, San Diego (UCSD), with faculty positions in the School of Global Policy and Strategy and the Department of Economics. He is also director of the Peter F. Cowhey Center on Global Transformation and a research associate at the National Bureau of Economic Research. Prior to joining UCSD, Dr. Graff Zivin was associate professor of economics in the Mailman School of Public Health and the School of International and Public Affairs at Columbia University, where he served as director of the Ph.D. program in sustainable development. He has published numerous articles on a wide range of topics in top economic, policy, and medical journals. His research interests include environmental, health, development, and innovation economics, with policy relevance as a guiding force behind all of his work. Dr. Graff Zivin received a Ph.D. and M.S. from the University of California, Berkeley and a B.A. from Rutgers University.
AMOL M. JOSHI
Dr. Amol M. Joshi is a Bern Beatty fellow and associate professor of strategic management at the Wake Forest University School of Business. Previously, he was assistant professor of strategy and entrepreneurship at Oregon State University’s College of Business. Dr. Joshi’s work is focused on technology entrepreneurship and investigating the impact of workforce diversity at agencies awarding Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) grants, as well as the likelihood of minority and women technology entrepreneurs receiving awards. His work also examines how inventors create and commercialize new products and technologies, and the problems associated with managing innovation across organizational boundaries. Dr. Joshi’s research is funded by a Kauffman Foundation Junior Faculty Fellowship grant and a National Science Foundation RAPID grant. He has also served as a research engineer, business manager, inventor, and entrepreneur, and
he trains teams of scientists and engineers on the best practices for launching new ventures from university and government research labs. Dr. Joshi serves as a member of the National Academies of Sciences, Engineering, and Medicine Committee on the Review of the SBIR/STTR Programs at the National Science Foundation; previously, he served on the Committee on the Review of the SBIR/STTR Programs at the Department of Energy (2018–2020). Dr. Joshi received a Ph.D. in business administration from the University of North Carolina at Chapel Hill, an M.B.A. and M.S. in engineering sciences from Dartmouth College, and a B.S. in electrical engineering (with highest honors) from the Georgia Institute of Technology.
Dr. Alicia Löffler is founding executive director of the Innovation and New Ventures Office (INVO), associate provost for Innovation and New Ventures, and associate vice president for research at Northwestern University. She is responsible for all short- and long-term strategies and operations for INVO, including all educational commercialization and new ventures. Dr. Löffler has served as advisor and director on multiple profit and nonprofit boards for biotech/medical and investment firms. Before becoming executive director of INVO, she was director of the Kellogg Center for Biotechnology Management, an educational and research organization focused on management of the biotechnology, pharmaceutical, and medical device sectors. Dr. Löffler received a B.S. from the University of Minnesota and a Ph.D. from the University of Massachusetts Amherst, and she completed postdoctoral training at the California Institute of Technology.
Dr. Amalia Miller is professor of economics and director of graduate studies at the University of Virginia, where she researches public finance, health economics, and industrial organization. She is also a research associate with the National Bureau of Economic Research and an IZA Institute of Labor Economics research fellow. From 2010 to 2017, Dr. Miller was an economist with the RAND Corporation and from 2004 to 2010 was assistant professor of economics at the University of Virginia. Dr. Miller has published research on such topics as privacy protection and personalized medicine, workforce reductions at woman-owned businesses, and workplace hierarchies. Her current research studies women in nontraditional occupations and information technology diffusion in medical care. Dr. Miller received a Ph.D. in economics from Stanford University.
MARY PAT MOYER
Dr. Mary Pat Moyer is founder, chief executive officer, and chief science officer of INCELL Corporation, a manufacturer and developer of media and cell
culture products with capabilities in manufacturing cell and tissue products, biologicals, and compounded drugs. Holding these positions since 1993, Dr. Moyer is an international authority in cell engineering science and manufacturing, as well as infectious disease science and vaccines. She is an adjunct professor in the department of surgery at the University of Texas Health San Antonio; she was a professor in the same department from 1992 to 1998. From 1988 to 1997, Dr. Moyer was coordinator and director of the University of Texas Health Science Center’s AIDS Research Laboratory. In 2019, Dr. Moyer was elected to the National Academy of Engineering for her record of entrepreneurship and development of cell lines, cell media, and testing technologies for regenerative medicine and biopharma products. Dr. Moyer received a Ph.D. in microbiology from The University of Texas at Austin.
Dr. Kyle Myers is assistant professor of business administration in the Technology and Operations Management unit of Harvard Business School (HBS), where he studies the economics of innovation. His research lies at the intersections of science, health care, and the commercialization process. More specifically, Dr. Myers is interested in the strategic choices and performance of scientists, the supply and demand of innovation in high-tech sectors, public versus private funding of research and development, and the management of innovation in large organizations, such as hospitals and pharmaceutical and engineering firms. His work has received funding from the Kauffman Foundation and was awarded the National Bureau of Economic Research (NBER) Value of Medical Research predoctoral scholarship. Prior to joining HBS, he served as a postdoctoral fellow at NBER and worked at the Centers for Disease Control and Prevention. Dr. Myers holds a Ph.D. from the Wharton School’s Department of Health Care Management and Economics, as well as an M.S. in health policy and management and a B.S. in biology from The Pennsylvania State University.
Dr. Bhaven Sampat is a professor in the Department of Health Policy and Management at Columbia University’s Mailman School of Public Health and a research associate at the National Bureau of Economic Research. An economist by training, Dr. Sampat is centrally interested in issues at the intersection of health policy and innovation policy. His current work examines the political economy of the National Institutes of Health, the effects of the World War II research effort on the rate and direction of postwar innovation, the globalization of pharmaceutical patent protection, and the roles of the government in pharmaceutical innovation. Dr. Sampat received a B.A., M.A., M.Phil., and Ph.D. in economics from Columbia University.
STEPHANIE S. SHIPP
Dr. Stephanie S. Shipp is deputy director and professor in the Social and Decision Analytics Division of the Biocomplexity Institute at the University of Virginia. With expertise in economics, evaluation, and policy analysis, Dr. Shipp leads, creates, and implements new programs to build data science capacity with cities and counties of all sizes, the official statistics community, and federal agencies. From 2007 to 2013, she was a researcher at the IDA Science and Technology Policy Institute, leading research and analysis of U.S. and global advanced manufacturing trends, technology transfer, and federal science and technology program evaluation. From 2000 to 2008, Dr. Shipp was a member of the Senior Executive Service and director of the Economic Assessment Office in the Advanced Technology Program at the National Institute of Standards and Technology. She expanded the economic evaluation capacity of that program by inviting and funding collaboration among academic and nonacademic researchers. She began her career at the Federal Reserve Board, followed by leadership positions at the Bureau of Labor Statistics and the Census Bureau. She has served on National Academies of Sciences, Engineering, and Medicine committees, using her knowledge of social sciences, statistics, policy, and innovation to evaluate and inform government science and technology programs. Dr. Shipp earned a Ph.D. in economics from George Washington University.
CLAY B. THORP
Clay B. Thorp has co-founded eight companies in the life sciences arena and, in 2000, co-founded Hatteras Venture Partners, a venture capital partnership that manages $700 million across six vintages. He has led investments in a range of life sciences companies, including G1 Therapeutics; Clearside Biomedical, Inc.; Lysosomal Therapeutics, Inc.; Asthmatx, Inc.; PhaseBio Pharmaceuticals; ArtusLabs; embrella; Kymera Therapeutics; and Synthematix, Inc. Mr. Thorp currently serves as chairman of PhaseBio Pharmaceuticals, and as a member of the board of directors of Clearside Biomedical, Inc.; StrideBio, Inc.; Vigil Neuroscience, Inc.; GeneCentric Therapeutics; and Seaport Diagnostics, Inc., and is a member of the Strategic and Scientific Advisory Board of Brii Biosciences. He serves on the Chancellor’s Philanthropic Committee at the University of North Carolina (UNC) at Chapel Hill, the Board of Visitors of the Lineberger Comprehensive Cancer Center at UNC-Chapel Hill, and on the board of the North Carolina School of Science and Mathematics Foundation. Mr. Thorp holds a masters of public policy from Harvard University and a B.A. in mathematics and art history from UNC-Chapel Hill.
Dr. Dashun Wang is professor of management and organizations at the Kellogg School of Management and the McCormick School of Engineering at
Northwestern University, where he is founding director of the Center for Science of Science and Innovation. Prior to serving at Northwestern, Dashun was assistant professor of information sciences and technology at The Pennsylvania State University and a research staff member at the IBM T. J. Watson Research Center. His current research focus is on the science of science, a quest to turn the scientific methods and curiosities upon ourselves, hoping to use and develop tools from complexity sciences and artificial intelligence to broadly explore the opportunities and promises offered by the recent data explosion in science. From 2009 to 2013, he was a research associate at the Harvard University Dana-Farber Cancer Institute. Dr. Wang has received multiple awards for his research and teaching, including the Air Force Office of Scientific Research Young Investigator award, Poets & Quants Best 40 Under 40 Professors, Thinkers50 Radar for 2021, and top scientific awards from the Complex Systems Society and Network Science Society, including the Erdős–Rényi Prize. Dr. Wang received a Ph.D. in physics from Northeastern University, where he was a member of the Center for Complex Network Research.
This page intentionally left blank.